Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Constantine-Cooke

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Alimentary Pharmacology & Therapeutics|March 18, 2022
Patterns of emergency admission for IBD patients over the last 10 years in Lothian, Scotland: a retrospective prevalent cohort analysisMathew Lyons, Lauranne A A P Derikx, James Fulforth, et al.
Alimentary Pharmacology & Therapeutics|June 16, 2025
Twenty-Year Trends in Colectomy Rates and Advanced Therapy Prescribing in Lothian, ScotlandAlexander T Elford, Nathan Constantine-Cooke, Phil W Jenkinson, et al.
Journal of Crohn'S & Colitis|June 5, 2021
Effectiveness and Safety of Adalimumab Biosimilar SB5 in Inflammatory Bowel Disease: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naïve SB5 Observational CohortsLauranne A A P Derikx, Heather W Dolby, Nikolas Plevris, et al.
Gut|January 19, 2026
Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn's and Colitis (PREdiCCt) prospective cohort studyNathan Constantine-Cooke, Beatriz Gros, Nikolas Plevris, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Alimentary Pharmacology & Therapeutics|March 18, 2022
Patterns of emergency admission for IBD patients over the last 10 years in Lothian, Scotland: a retrospective prevalent cohort analysisMathew Lyons, Lauranne A A P Derikx, James Fulforth, et al.
Alimentary Pharmacology & Therapeutics|June 16, 2025
Twenty-Year Trends in Colectomy Rates and Advanced Therapy Prescribing in Lothian, ScotlandAlexander T Elford, Nathan Constantine-Cooke, Phil W Jenkinson, et al.
Journal of Crohn'S & Colitis|June 5, 2021
Effectiveness and Safety of Adalimumab Biosimilar SB5 in Inflammatory Bowel Disease: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naïve SB5 Observational CohortsLauranne A A P Derikx, Heather W Dolby, Nikolas Plevris, et al.
Gut|January 19, 2026
Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn's and Colitis (PREdiCCt) prospective cohort studyNathan Constantine-Cooke, Beatriz Gros, Nikolas Plevris, et al.
Pageof 2